- Clb5 Clb6 Mutants
- clb5∆ clb6∆
- TAB6-1 clb5∆ clb6∆
- cdc20∆ clb5∆
- cdc20∆ pds1∆ clb5∆
- CLB2-db∆ clb5∆
- CLB2-db∆ clb5∆ in galactose
- cln1∆ cln2∆ clb5∆ clb6∆
- CLB5-db∆
- CLB5-db∆ sic1∆
- CLB5-db∆ pds1∆
- CLB5-db∆ pds1∆ cdc20∆
- GAL-CLB5
- GAL-CLB5 cdh1∆
- GAL-CLB5 sic1∆
- GAL-CLB5-db∆
- cln1∆ cln2∆ cln3∆ multi-copy CLB5
- cln1∆ cln2∆ cln3∆ GAL-CLB5
cln1∆ cln2∆ cln3∆ multi-copy CLB5
debug: ,
test user =
test db =
Simulation:
Change of parameters: ksn2'= ksn2"=0, Dn3=0, ksb5'=0.0016, ksb5"=0.01 (=2 copies).
Length of G1 phase: 40.6 min.
Mass at division: 10.68
Experiments:
Epstein, C.B. and Cross, F.R. (1992). CLB5: a novel B cyclin from budding yeast with a role in S phase. Genes Dev. 6:1695-1706.
[Abstract] [Article]
[Abstract] [Article]
Experimental results: Viable. Fig. 1, a low copy number (CEN) plasmid carrying the CLB5 gene can suppress the lethality of triple-cln deletion.
Comments: